UniProt ID | FOXJ3_HUMAN | |
---|---|---|
UniProt AC | Q9UPW0 | |
Protein Name | Forkhead box protein J3 | |
Gene Name | FOXJ3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 622 | |
Subcellular Localization | Nucleus . | |
Protein Description | Transcriptional activator of MEF2C involved in the regulation pf adult muscle fiber type identity and skeletal muscle regeneration.. | |
Protein Sequence | MGLYGQACPSVTSLRMTSELESSLTSMDWLPQLTMRAAIQKSDATQNAHGTGISKKNALLDPNTTLDQEEVQQHKDGKPPYSYASLITFAINSSPKKKMTLSEIYQWICDNFPYYREAGSGWKNSIRHNLSLNKCFLKVPRSKDDPGKGSYWAIDTNPKEDVLPTRPKKRARSVERASTPYSIDSDSLGMECIISGSASPTLAINTVTNKVTLYNTDQDGSDSPRSSLNNSLSDQSLASVNLNSVGSVHSYTPVTSHPESVSQSLTPQQQPQYNLPERDKQLLFSEYNFEDLSASFRSLYKSVFEQSLSQQGLMNIPSESSQQSHTSCTYQHSPSSTVSTHPHSNQSSLSNSHGSGLNTTGSNSVAQVSLSHPQMHTQPSPHPPHRPHGLPQHPQRSPHPAPHPQQHSQLQSPHPQHPSPHQHIQHHPNHQHQTLTHQAPPPPQQVSCNSGVSNDWYATLDMLKESCRIASSVNWSDVDLSQFQGLMESMRQADLKNWSLDQVQFADLCSSLNQFFTQTGLIHSQSNVQQNVCHGAMHPTKPSQHIGTGNLYIDSRQNLPPSVMPPPGYPHIPQALSTPGTTMAGHHRAMNQQHMMPSQAFQMRRSLPPDDIQDDFDWDSIV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
4 | Phosphorylation | ----MGLYGQACPSV ----CCCCCCCCCCC | 11.06 | 24043423 | |
10 | Phosphorylation | LYGQACPSVTSLRMT CCCCCCCCCCCCCCC | 37.60 | 24043423 | |
12 | Phosphorylation | GQACPSVTSLRMTSE CCCCCCCCCCCCCHH | 26.78 | 24043423 | |
13 | Phosphorylation | QACPSVTSLRMTSEL CCCCCCCCCCCCHHH | 16.30 | 24043423 | |
17 | Phosphorylation | SVTSLRMTSELESSL CCCCCCCCHHHHHHC | 16.77 | 24043423 | |
18 | Phosphorylation | VTSLRMTSELESSLT CCCCCCCHHHHHHCC | 30.73 | 24043423 | |
22 | Phosphorylation | RMTSELESSLTSMDW CCCHHHHHHCCCCCH | 43.18 | 24043423 | |
23 | Phosphorylation | MTSELESSLTSMDWL CCHHHHHHCCCCCHH | 26.70 | 28348404 | |
25 | Phosphorylation | SELESSLTSMDWLPQ HHHHHHCCCCCHHHH | 24.77 | 28348404 | |
26 | Phosphorylation | ELESSLTSMDWLPQL HHHHHCCCCCHHHHH | 21.75 | 24043423 | |
34 | Phosphorylation | MDWLPQLTMRAAIQK CCHHHHHHHHHHHHH | 10.20 | 24043423 | |
41 | Acetylation | TMRAAIQKSDATQNA HHHHHHHHCHHCCCC | 44.16 | 25953088 | |
41 | Sumoylation | TMRAAIQKSDATQNA HHHHHHHHCHHCCCC | 44.16 | - | |
41 | Ubiquitination | TMRAAIQKSDATQNA HHHHHHHHCHHCCCC | 44.16 | 29967540 | |
41 | Sumoylation | TMRAAIQKSDATQNA HHHHHHHHCHHCCCC | 44.16 | - | |
45 | Phosphorylation | AIQKSDATQNAHGTG HHHHCHHCCCCCCCC | 27.61 | - | |
51 | Phosphorylation | ATQNAHGTGISKKNA HCCCCCCCCCCHHHC | 22.83 | - | |
55 | Ubiquitination | AHGTGISKKNALLDP CCCCCCCHHHCCCCC | 48.39 | 29967540 | |
55 | Acetylation | AHGTGISKKNALLDP CCCCCCCHHHCCCCC | 48.39 | 25953088 | |
56 | Ubiquitination | HGTGISKKNALLDPN CCCCCCHHHCCCCCC | 40.43 | 29967540 | |
64 | Phosphorylation | NALLDPNTTLDQEEV HCCCCCCCCCCHHHH | 33.84 | 28555341 | |
65 | Phosphorylation | ALLDPNTTLDQEEVQ CCCCCCCCCCHHHHH | 34.67 | 25159151 | |
81 | Phosphorylation | HKDGKPPYSYASLIT CCCCCCCCCHHHHHH | 23.88 | 20090780 | |
93 | Phosphorylation | LITFAINSSPKKKMT HHHHHHCCCCCCCCC | 41.74 | 28555341 | |
131 | Phosphorylation | NSIRHNLSLNKCFLK HHHHHCCCCCCEEEE | 34.90 | 21712546 | |
148 | Acetylation | RSKDDPGKGSYWAID CCCCCCCCCCEEEEC | 50.50 | 26051181 | |
148 | Ubiquitination | RSKDDPGKGSYWAID CCCCCCCCCCEEEEC | 50.50 | 29967540 | |
173 (in isoform 2) | Phosphorylation | - | 27.61 | 28450419 | |
173 | Phosphorylation | RPKKRARSVERASTP CCCHHCCCCCCCCCC | 27.61 | 28102081 | |
178 (in isoform 2) | Phosphorylation | - | 35.82 | 22617229 | |
178 | Phosphorylation | ARSVERASTPYSIDS CCCCCCCCCCCEECC | 35.82 | 27251275 | |
179 | Phosphorylation | RSVERASTPYSIDSD CCCCCCCCCCEECCC | 25.84 | 24719451 | |
180 (in isoform 2) | Phosphorylation | - | 20.55 | 23090842 | |
181 | Phosphorylation | VERASTPYSIDSDSL CCCCCCCCEECCCCC | 20.53 | 27251275 | |
182 | Phosphorylation | ERASTPYSIDSDSLG CCCCCCCEECCCCCC | 22.56 | 28857561 | |
187 (in isoform 2) | Phosphorylation | - | 30.67 | 25159151 | |
187 | Phosphorylation | PYSIDSDSLGMECII CCEECCCCCCCEEEE | 30.67 | 27251275 | |
189 (in isoform 2) | Phosphorylation | - | 17.50 | 25849741 | |
195 | Phosphorylation | LGMECIISGSASPTL CCCEEEEECCCCCCE | 13.54 | 27251275 | |
197 | Phosphorylation | MECIISGSASPTLAI CEEEEECCCCCCEEE | 20.84 | 30108239 | |
199 | Phosphorylation | CIISGSASPTLAINT EEEECCCCCCEEEEE | 21.80 | 28464451 | |
201 | Phosphorylation | ISGSASPTLAINTVT EECCCCCCEEEEECC | 26.73 | 27251275 | |
206 | Phosphorylation | SPTLAINTVTNKVTL CCCEEEEECCCEEEE | 23.69 | 27251275 | |
208 | Phosphorylation | TLAINTVTNKVTLYN CEEEEECCCEEEEEE | 27.55 | 27251275 | |
212 | Phosphorylation | NTVTNKVTLYNTDQD EECCCEEEEEECCCC | 25.74 | 30266825 | |
214 | Phosphorylation | VTNKVTLYNTDQDGS CCCEEEEEECCCCCC | 13.47 | 30266825 | |
216 | Phosphorylation | NKVTLYNTDQDGSDS CEEEEEECCCCCCCC | 22.83 | 30266825 | |
221 | Phosphorylation | YNTDQDGSDSPRSSL EECCCCCCCCCCHHH | 43.11 | 30266825 | |
223 | Phosphorylation | TDQDGSDSPRSSLNN CCCCCCCCCCHHHCC | 24.74 | 22167270 | |
239 | Phosphorylation | LSDQSLASVNLNSVG CCCCCCCCCCCCCCC | 19.48 | 28464451 | |
246 | Ubiquitination | SVNLNSVGSVHSYTP CCCCCCCCCEEECCC | 24.62 | 29967540 | |
260 | Phosphorylation | PVTSHPESVSQSLTP CCCCCCHHHHCCCCC | 31.36 | 26074081 | |
262 | Phosphorylation | TSHPESVSQSLTPQQ CCCCHHHHCCCCCCC | 24.27 | 26074081 | |
264 | Phosphorylation | HPESVSQSLTPQQQP CCHHHHCCCCCCCCC | 27.06 | 26074081 | |
266 | Phosphorylation | ESVSQSLTPQQQPQY HHHHCCCCCCCCCCC | 25.05 | 26074081 | |
273 | Phosphorylation | TPQQQPQYNLPERDK CCCCCCCCCCCHHHH | 25.91 | 26074081 | |
280 | Ubiquitination | YNLPERDKQLLFSEY CCCCHHHHHHHHCCC | 49.41 | 29967540 | |
285 | Phosphorylation | RDKQLLFSEYNFEDL HHHHHHHCCCCHHHH | 38.86 | 26074081 | |
293 | Phosphorylation | EYNFEDLSASFRSLY CCCHHHHHHHHHHHH | 33.90 | 28348404 | |
295 | Phosphorylation | NFEDLSASFRSLYKS CHHHHHHHHHHHHHH | 20.16 | 22817900 | |
350 | Phosphorylation | HSNQSSLSNSHGSGL CCCCCCCCCCCCCCC | 37.93 | 26074081 | |
352 | Phosphorylation | NQSSLSNSHGSGLNT CCCCCCCCCCCCCCC | 26.33 | 26074081 | |
471 | Phosphorylation | KESCRIASSVNWSDV HHHCCCCCCCCHHHC | 32.23 | 27251275 | |
472 | Phosphorylation | ESCRIASSVNWSDVD HHCCCCCCCCHHHCC | 15.50 | 22817900 | |
476 | Phosphorylation | IASSVNWSDVDLSQF CCCCCCHHHCCHHHH | 23.66 | 28102081 | |
489 | Phosphorylation | QFQGLMESMRQADLK HHHHHHHHHHHHHHH | 12.80 | 22817900 | |
606 | Phosphorylation | QAFQMRRSLPPDDIQ HHHHHHHCCCCCCCC | 34.56 | 10470851 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of FOXJ3_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FOXJ3_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FOXJ3_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
ALBU_HUMAN | ALB | physical | 25609649 | |
P53_HUMAN | TP53 | physical | 25609649 | |
RAGP1_HUMAN | RANGAP1 | physical | 25609649 | |
SMCA5_HUMAN | SMARCA5 | physical | 25609649 | |
UBR2_HUMAN | UBR2 | physical | 25609649 | |
ZBT10_HUMAN | ZBTB10 | physical | 25609649 | |
RFA2_HUMAN | RPA2 | physical | 25609649 | |
UBP11_HUMAN | USP11 | physical | 25609649 | |
FOXJ1_HUMAN | FOXJ1 | physical | 25609649 | |
PSB4_HUMAN | PSMB4 | physical | 25609649 | |
ZBTB2_HUMAN | ZBTB2 | physical | 25609649 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-223; SER-295 ANDSER-489, AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-223, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-223, AND MASSSPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-223, AND MASSSPECTROMETRY. |